skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Location: Carle - Heart & Vascular Institute
Body site or condition: Cardiovascular
Department: Cardiology

RIN-PH-304 | PERFECT

The primary objective of this study is to demonstrate the efficacy of inhaled treprostinil compared to placebo in improving exercise ability as measured by change from baseline in 6-Minute Walk Distance (6MWD) following 12 weeks of active treatment in participants with PH-COPD.

Apply Now